Literature DB >> 23667900

Three-dimensional cultures modeling premalignant progression of human breast epithelial cells: role of cysteine cathepsins.

Stefanie R Mullins1, Mansoureth Sameni, Galia Blum, Matthew Bogyo, Bonnie F Sloane, Kamiar Moin.   

Abstract

The expression of the cysteine protease cathepsin B is increased in early stages of human breast cancer.To assess the potential role of cathepsin B in premalignant progression of breast epithelial cells, we employed a 3D reconstituted basement membrane overlay culture model of MCF10A human breast epithelial cells and isogenic variants that replicate the in vivo phenotypes of hyper plasia(MCF10AneoT) and atypical hyperplasia (MCF10AT1). MCF10A cells developed into polarized acinar structures with central lumens. In contrast, MCF10AneoT and MCF10AT1 cells form larger structures in which the lumens are filled with cells. CA074Me, a cell-permeable inhibitor selective for the cysteine cathepsins B and L,reduced proliferation and increased apoptosis of MCF10A, MCF10AneoT and MCF10AT1 cells in 3D culture. We detected active cysteine cathepsins in the isogenic MCF10 variants in 3D culture with GB111, a cell-permeable activity based probe, and established differential inhibition of cathepsin B in our 3D cultures. We conclude that cathepsin B promotes proliferation and premalignant progression of breast epithelial cells. These findings are consistent with studies by others showing that deletion of cathepsin B in the transgenic MMTV-PyMT mice, a murine model that is predisposed to development of mammary cancer, reduces malignant progression.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23667900      PMCID: PMC3789365          DOI: 10.1515/hsz-2012-0252

Source DB:  PubMed          Journal:  Biol Chem        ISSN: 1431-6730            Impact factor:   3.915


  52 in total

1.  Transformation of human breast epithelial cells by c-Ha-ras oncogene.

Authors:  F Basolo; J Elliott; L Tait; X Q Chen; T Maloney; I H Russo; R Pauley; S Momiki; J Caamano; A J Klein-Szanto
Journal:  Mol Carcinog       Date:  1991       Impact factor: 4.784

2.  Inhibition of calpain in intact platelets by the thiol protease inhibitor E-64d.

Authors:  E B McGowan; E Becker; T C Detwiler
Journal:  Biochem Biophys Res Commun       Date:  1989-01-31       Impact factor: 3.575

3.  Feasibility of drug screening with panels of human tumor cell lines using a microculture tetrazolium assay.

Authors:  M C Alley; D A Scudiero; A Monks; M L Hursey; M J Czerwinski; D L Fine; B J Abbott; J G Mayo; R H Shoemaker; M R Boyd
Journal:  Cancer Res       Date:  1988-02-01       Impact factor: 12.701

4.  Inhibition of cysteine proteinases in lysosomes and whole cells.

Authors:  D Wilcox; R W Mason
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

5.  Human tumour cathepsin B. Comparison with normal liver cathepsin B.

Authors:  K Moin; N A Day; M Sameni; S Hasnain; T Hirama; B F Sloane
Journal:  Biochem J       Date:  1992-07-15       Impact factor: 3.857

6.  Tumor cell-derived and macrophage-derived cathepsin B promotes progression and lung metastasis of mammary cancer.

Authors:  Olga Vasiljeva; Anna Papazoglou; Achim Krüger; Harald Brodoefel; Matvey Korovin; Jan Deussing; Nicole Augustin; Boye S Nielsen; Kasper Almholt; Matthew Bogyo; Christoph Peters; Thomas Reinheckel
Journal:  Cancer Res       Date:  2006-05-15       Impact factor: 12.701

Review 7.  The role of cathepsins in osteoporosis and arthritis: rationale for the design of new therapeutics.

Authors:  Yoshiyuki Yasuda; Jadwiga Kaleta; Dieter Brömme
Journal:  Adv Drug Deliv Rev       Date:  2005-04-15       Impact factor: 15.470

8.  MCF10AT: a model for the evolution of cancer from proliferative breast disease.

Authors:  P J Dawson; S R Wolman; L Tait; G H Heppner; F R Miller
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

9.  Xenograft model of progressive human proliferative breast disease.

Authors:  F R Miller; H D Soule; L Tait; R J Pauley; S R Wolman; P J Dawson; G H Heppner
Journal:  J Natl Cancer Inst       Date:  1993-11-03       Impact factor: 13.506

10.  Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis.

Authors:  James E Korkola; Sandy DeVries; Jane Fridlyand; E Shelley Hwang; Anne L H Estep; Yunn-Yi Chen; Karen L Chew; Shanaz H Dairkee; Ronald M Jensen; Frederic M Waldman
Journal:  Cancer Res       Date:  2003-11-01       Impact factor: 12.701

View more
  17 in total

Review 1.  Pathomimetic cancer avatars for live-cell imaging of protease activity.

Authors:  Kyungmin Ji; Joshua Heyza; Dora Cavallo-Medved; Bonnie F Sloane
Journal:  Biochimie       Date:  2015-09-12       Impact factor: 4.079

2.  Photoactivated inhibition of cathepsin K in a 3D tumor model.

Authors:  Mackenzie K Herroon; Rajgopal Sharma; Erandi Rajagurubandara; Claudia Turro; Jeremy J Kodanko; Izabela Podgorski
Journal:  Biol Chem       Date:  2016-06-01       Impact factor: 3.915

3.  Cabozantinib (XL184) Inhibits Growth and Invasion of Preclinical TNBC Models.

Authors:  Mansoureh Sameni; Elizabeth A Tovar; Curt J Essenburg; Anita Chalasani; Erik S Linklater; Andrew Borgman; David M Cherba; Arulselvi Anbalagan; Mary E Winn; Carrie R Graveel; Bonnie F Sloane
Journal:  Clin Cancer Res       Date:  2015-10-02       Impact factor: 12.531

4.  Catch and Release Photosensitizers: Combining Dual-Action Ruthenium Complexes with Protease Inactivation for Targeting Invasive Cancers.

Authors:  Karan Arora; Mackenzie Herroon; Malik H Al-Afyouni; Nicholas P Toupin; Thomas N Rohrabaugh; Lauren M Loftus; Izabela Podgorski; Claudia Turro; Jeremy J Kodanko
Journal:  J Am Chem Soc       Date:  2018-10-22       Impact factor: 15.419

Review 5.  Next-generation sequencing: a powerful tool for the discovery of molecular markers in breast ductal carcinoma in situ.

Authors:  Hitchintan Kaur; Shihong Mao; Seema Shah; David H Gorski; Stephen A Krawetz; Bonnie F Sloane; Raymond R Mattingly
Journal:  Expert Rev Mol Diagn       Date:  2013-03       Impact factor: 5.225

6.  Cathepsin B-deficient mice as source of monoclonal anti-cathepsin B antibodies.

Authors:  Ekkehard Weber; Elena Barbulescu; Rita Medek; Thomas Reinheckel; Mansoureh Sameni; Arulselvi Anbalagan; Kamiar Moin; Bonnie F Sloane
Journal:  Biol Chem       Date:  2015-03       Impact factor: 3.915

7.  Photodynamic therapy as an effective therapeutic approach in MAME models of inflammatory breast cancer.

Authors:  Neha Aggarwal; Ann Marie Santiago; David Kessel; Bonnie F Sloane
Journal:  Breast Cancer Res Treat       Date:  2015-10-26       Impact factor: 4.872

8.  Externally added cystatin C reduces growth of A375 melanoma cells by increasing cell cycle time.

Authors:  Hanna Wallin; Samar Hunaiti; Magnus Abrahamson
Journal:  FEBS Open Bio       Date:  2021-05-02       Impact factor: 2.693

9.  Metabotropic glutamate receptor-1 contributes to progression in triple negative breast cancer.

Authors:  Malathi Banda; Cecilia L Speyer; Sara N Semma; Kingsley O Osuala; Nicole Kounalakis; Keila E Torres Torres; Nicola J Barnard; Hyunjin J Kim; Bonnie F Sloane; Fred R Miller; James S Goydos; David H Gorski
Journal:  PLoS One       Date:  2014-01-03       Impact factor: 3.240

10.  Il-6 signaling between ductal carcinoma in situ cells and carcinoma-associated fibroblasts mediates tumor cell growth and migration.

Authors:  Kingsley O Osuala; Mansoureh Sameni; Seema Shah; Neha Aggarwal; Michelle L Simonait; Omar E Franco; Yan Hong; Simon W Hayward; Fariba Behbod; Raymond R Mattingly; Bonnie F Sloane
Journal:  BMC Cancer       Date:  2015-08-13       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.